Heart failure is associated with exaggerated endothelial ischaemia-reperfusion injury and attenuated effect of ischaemic preconditioning

European Journal of Preventive Cardiology

Volumn 23, Issue 1, 2016, Pages 33-40

  Seeger, Joost P H ^a,b   Benda, Nathalie M M ^a   Riksen, Niels P ^a   Van Dijk, Arie P J ^b   Bellersen, Louise ^b   Hopman, Maria T E ^a   Cable, N Timothy ^a   Thijssen, Dick H J ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Cardiovascular disease; cardiovascular risk; endothelial function; flow mediated dilation; ischaemia

Indexed keywords

CHOLESTEROL; GLUCOSE;

AGED; ALLOMETRY; ARTERY DIAMETER; ARTICLE; BODY HEIGHT; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM INJURY; FEMALE; GLUCOSE BLOOD LEVEL; HAND GRIP; HEART FAILURE; HUMAN; ISCHEMIC PRECONDITIONING; MALE; NEW YORK HEART ASSOCIATION CLASS; PNEUMATIC CUFF; PRIORITY JOURNAL; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; ANALYSIS OF VARIANCE; BLOOD FLOW; COMPLICATION; CONTROLLED CLINICAL TRIAL; FOREARM; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASODILATATION;

AGED; ANALYSIS OF VARIANCE; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HEART FAILURE; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; REPERFUSION INJURY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 84949845314     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314558377     Document Type: Article

References (34)

1. Koopman C, Bots ML, van Dis I, et al. Shifts in the age distribution and from acute to chronic coronary heart disease hospitalizations. Eur J Prev Cardiol. Epub ahead of print 30 July 2014. DOI: 10.1177/2047487314544975.
2. Murray AJ, Lygate CA, Cole MA, et al. Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovasc Res 2006; 71: 149-157.
3. Devan AE, Umpierre D, Harrison ML, et al. Endothelial ischemia-reperfusion injury in humans: Association with age and habitual exercise. Am J Physiol 2011; 300: H813-H819.
4. Boengler K, Schulz R, Heusch G,. Loss of cardioprotection with ageing. Cardiovasc Res 2009; 83: 247-261.
5. Seal JB, Gewertz BL,. Vascular dysfunction in ischemis-reperfusion injury. Ann Vasc Surg 2005; 19: 572-584.
6. Hoskins DE, Ignasiak DP, Saganek LJ, et al. Myocardial infarct size is smaller in dogs with pacing-induced heart failure. Cardiovasc Res 1996; 32: 238-247.
7. Sharikabad MN, Aronsen JM, Haugen E, et al. Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance. Am J Physiol Heart Circ Physiol 2009; 296: H787-H795.
8. Murry CE, Jennings RB, Reimer KA,. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
9. van den Munckhof I, Riksen N, Seeger JP, et al. Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemis-reperfusion injury in humans. Am J Physiol Heart Circ Physiol 2013; 304: H1727-H1732.
10. Kharbanda RK, Peters M, Walton B, et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001; 103: 1624-1630.
11. Loukogeorgakis SP, van den Berg MJ, Sofat R, et al. Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 2010; 121: 2310-2316.
12. Ovize M, Thibault H, Przyklenk K,. Myocardial conditioning: Opportunities for clinical translation. Cardiovasc Res 2013; 113: 439-450.
13. Ghosh S, Standen NB, Galinianes M,. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001; 37: 711-718.
14. Miki T, Miura T, Tsuchida A, et al. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 2000; 102: 458-463.
15. Andersen A, Povlsen JA, Botker HE, et al. Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning. Eur J Heart Fail 2013; 15: 1208-1214.
16. Naylor LH, Weisbrod CJ, O'Driscoll G, et al. Measuring peripheral resistance and conduit arterial structure in humans using Doppler ultrasound. J Appl Physiol 2005; 98: 2311-2315.
17. Takase B, Uehata A, Akima T, et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82: 1535-1539. A7-A8.
18. Inaba Y, Chen JA, Bergmann SR,. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: A meta-analysis. Int J Cardiovasc Imaging 2010; 26: 631-640.
19. Ras RT, Streppel MT, Draijer R, et al. Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis. Int J Cardiol 2013; 168: 344-351.
20. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am J Physiol 2011; 300: H2-H12.
21. Black MA, Cable NT, Thijssen DH, et al. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol 2009; 297: H1109-H1116.
22. Thijssen DH, Dawson EA, Tinken TM, et al. Retrograde flow and shear rate acutely impair endothelial function in humans. Hypertension 2009; 53: 986-992.
23. Atkinson G, Batterham AM, Thijssen DH, et al. A new approach to improve the specificity of flow-mediated dilation for indicating endothelial function in cardiovascular research. J Hypertens 2013; 31: 287-291.
24. Di Lisa F, Canton M, Menabo R, et al. Mitochondria and reperfusion injury. The role of permeability transition. Basic Res Cardiol 2003; 98: 235-241.
25. Kaul N, Siveski-Iliskovic N, Hill M, et al. Free radicals and the heart. J Pharmacol Toxicol Methods 1993; 30: 55-67.
26. MacCarthy PA, Shah AM,. Oxidative stress and heart failure. Coron Artery Dis 2003; 14: 109-113.
27. Ferdinandy P, Schulz R, Baxter GF,. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59: 418-458.
28. Whittington HJ, Harding I, Stephenson CI, et al. Cardioprotection in the aging, diabetic heart: The loss of protective Akt signalling. Cardiovasc Res 2013; 99: 694-704.
29. Miki T, Miura T, Tanno M, et al. Interruption of signal transduction between G protein and PKC-epsilon underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts. Mol Cell Biochem 2003; 247: 185-193.
30. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial. Lancet 2010; 375: 727-734.
31. Thielmann M, Kottenberg E, Kleinbongard P, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-centre randomised, double-blind, controlled trial. Lancet 2013; 382: 597-604.
32. Hausenloy DJ, Baxter G, Bell R, et al. Translating novel strategies for cardioprotection: The Hatter Workshop Recommendations. Basic Res Cardiol 2010; 105: 677-686.
33. Colombo PC, Banchs JE, Celaj S, et al. Endothelial cell activation in patients with decompensated heart failure. Circulation 2005; 111: 58-62.
34. Liuni A, Luca MC, Gori T, et al. Loss of the preconditioning effect of rosuvastatin during sustained therapy: A human in vivo study. Am J Physiol Heart Circ Physiol 2012; 302: H153-H158.